https://pubmed.ncbi.nlm.nih.gov/34978255/
Comparative efficacy of tisagenlecleucel and lisocabtagene maraleucel among adults with...
This study compared overall survival (OS), progression-free survival (PFS), complete response rate (CRR), and overall response rate (ORR) of tisagenlecleucel...
lisocabtagene maraleucelcomparativeefficacytisagenlecleucelamong
https://pubmed.ncbi.nlm.nih.gov/37295445/
Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND...
Juno Therapeutics, a Bristol-Myers Squibb Company.
chronic lymphocytic leukaemialisocabtagene maraleucelsmalllymphomatranscend
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-breyanzi-lisocabtagene-maraleucel
FDA D.I.S.C.O. Burst Edition: Breyanzi (lisocabtagene maraleucel) | FDA
Listen to a soundcast of the Feb 5th 2021 FDA approval of Breyanzi for treatment of adult patients with relapsed or refractory large B-cell lymphoma after two...
s c od ifda